FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379600384> ?p ?o ?g. }

• W4379600384 endingPage "e064151" @default.
• W4379600384 startingPage "e064151" @default.
• W4379600384 abstract "Approximately 15%-20% of the adult population self-report symptoms of addictive eating. There are currently limited options for management. Motivational interviewing-based interventions, containing personalised coping skills training, have been found to be effective for behaviour change in addictive disorders (eg, alcohol). This project builds upon foundations of an addictive eating feasibility study previously conducted and co-design process involving consumers. The primary aim of this study is to examine the efficacy of a telehealth intervention targeting addictive eating symptoms in Australian adults compared with passive intervention and control groups.This three-arm randomised controlled trial will recruit participants 18-85 years, endorsing ≥3 symptoms on the Yale Food Addiction Scale (YFAS) 2.0, with body mass index >18.5 kg/m2. Addictive eating symptoms are assessed at baseline (pre-intervention), 3 months (post-intervention) and 6 months. Other outcomes include dietary intake and quality, depression, anxiety, stress, quality of life, physical activity and sleep hygiene. Using a multicomponent clinician-led approach, the active intervention consists of five telehealth sessions (15-45 min each) delivered by a dietitian over 3 months. The intervention uses personalised feedback, skill-building exercises, reflective activities and goal setting. Participants are provided with a workbook and website access. The passive intervention group receives the intervention via a self-guided approach with access to the workbook and website (no telehealth). The control group receives personalised written dietary feedback at baseline and participants advised to follow their usual dietary pattern for 6 months. The control group will be offered the passive intervention after 6 months. The primary endpoint is YFAS symptom scores at 3 months. A cost-consequence analysis will determine intervention costs alongside mean change outcomes.Human Research Ethics Committee of University of Newcastle, Australia provided approval (H-2021-0100). Findings will be disseminated via publication in peer-reviewed journals, conference presentations, community presentations and student theses.Australia New Zealand Clinical Trials Registry (ACTRN12621001079831)." @default.
• W4379600384 created "2023-06-08" @default.
• W4379600384 creator A5000516677 @default.
• W4379600384 creator A5001897335 @default.
• W4379600384 creator A5020058141 @default.
• W4379600384 creator A5023673789 @default.
• W4379600384 creator A5025984821 @default.
• W4379600384 creator A5045350296 @default.
• W4379600384 creator A5046323533 @default.
• W4379600384 creator A5071199401 @default.
• W4379600384 creator A5076305088 @default.
• W4379600384 creator A5077406877 @default.
• W4379600384 creator A5078761899 @default.
• W4379600384 creator A5084278157 @default.
• W4379600384 creator A5089465141 @default.
• W4379600384 creator A5032042184 @default.
• W4379600384 date "2023-06-01" @default.
• W4379600384 modified "2023-10-12" @default.
• W4379600384 title "Examining the efficacy of a telehealth intervention targeting addictive eating in Australian adults (the TRACE Programme): a randomised controlled trial protocol" @default.
• W4379600384 cites W1575941956 @default.
• W4379600384 cites W1926404136 @default.
• W4379600384 cites W1968549322 @default.
• W4379600384 cites W1977376374 @default.
• W4379600384 cites W1984056981 @default.
• W4379600384 cites W2027496959 @default.
• W4379600384 cites W2028157869 @default.
• W4379600384 cites W2032541700 @default.
• W4379600384 cites W2041981133 @default.
• W4379600384 cites W2043705607 @default.
• W4379600384 cites W2048533792 @default.
• W4379600384 cites W2065494118 @default.
• W4379600384 cites W2070081862 @default.
• W4379600384 cites W2076552277 @default.
• W4379600384 cites W2080328342 @default.
• W4379600384 cites W2086564524 @default.
• W4379600384 cites W2086822427 @default.
• W4379600384 cites W2089580658 @default.
• W4379600384 cites W2093274439 @default.
• W4379600384 cites W2100430601 @default.
• W4379600384 cites W2108696783 @default.
• W4379600384 cites W2115771625 @default.
• W4379600384 cites W2145555293 @default.
• W4379600384 cites W2150524442 @default.
• W4379600384 cites W2151487996 @default.
• W4379600384 cites W2153836018 @default.
• W4379600384 cites W2155355450 @default.
• W4379600384 cites W2166023752 @default.
• W4379600384 cites W2313471168 @default.
• W4379600384 cites W2394736626 @default.
• W4379600384 cites W2469447473 @default.
• W4379600384 cites W2513989113 @default.
• W4379600384 cites W2514021919 @default.
• W4379600384 cites W2518654609 @default.
• W4379600384 cites W2560051844 @default.
• W4379600384 cites W2601893303 @default.
• W4379600384 cites W2617126691 @default.
• W4379600384 cites W2746943572 @default.
• W4379600384 cites W2748223292 @default.
• W4379600384 cites W2764041985 @default.
• W4379600384 cites W2778880807 @default.
• W4379600384 cites W2789828107 @default.
• W4379600384 cites W2791737503 @default.
• W4379600384 cites W2792905072 @default.
• W4379600384 cites W2802698078 @default.
• W4379600384 cites W2885425227 @default.
• W4379600384 cites W2921252842 @default.
• W4379600384 cites W2928467655 @default.
• W4379600384 cites W2940965430 @default.
• W4379600384 cites W2944434778 @default.
• W4379600384 cites W2947420017 @default.
• W4379600384 cites W2987569638 @default.
• W4379600384 cites W3000352544 @default.
• W4379600384 cites W3003609128 @default.
• W4379600384 cites W3014826794 @default.
• W4379600384 cites W3022729707 @default.
• W4379600384 cites W3037563332 @default.
• W4379600384 cites W3088959799 @default.
• W4379600384 cites W3089607113 @default.
• W4379600384 cites W3106861108 @default.
• W4379600384 cites W3109246759 @default.
• W4379600384 cites W3135361861 @default.
• W4379600384 cites W3165345793 @default.
• W4379600384 cites W3177211278 @default.
• W4379600384 cites W3205235034 @default.
• W4379600384 cites W4207007419 @default.
• W4379600384 cites W4220887092 @default.
• W4379600384 cites W4225471009 @default.
• W4379600384 cites W4236805817 @default.
• W4379600384 cites W4247665917 @default.
• W4379600384 cites W4281947243 @default.
• W4379600384 cites W4285301321 @default.
• W4379600384 cites W4291155801 @default.
• W4379600384 cites W4292412213 @default.
• W4379600384 cites W4297546144 @default.
• W4379600384 cites W4313500297 @default.
• W4379600384 cites W605679381 @default.
• W4379600384 doi "https://doi.org/10.1136/bmjopen-2022-064151" @default.
• W4379600384 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37280025" @default.

• next